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Background: Genes that contribute to the risk of developing Chronic Obstructive Pulmonary
Disease (COPD) have been identified, but an attempt to accurately quantify the total genetic
contribution to COPD has to our knowledge never been conducted.
Methods: Hospital discharge diagnoses data on COPD were analysed in 22,422 Danish twin
pairs, 20e71 years of age. The analyses were replicated in a population of 27,668 Swedish twin
pairs, 45e108 years of age. A Cox-regression model was applied to the discordant time from
the age at first hospital admission for COPD in the co-twin of an affected twin. Latent factor
models were used to estimate genetic and environmental effects.
Results: The probandwise concordance rate for COPD was higher in monozygotic (MZ) than in
dizygotic (DZ) twins, 0.19 vs. 0.07 (p Z 0.08) in the Danish population, and 0.20 vs. 0.08
(p Z 0.006) in the Swedish population.
After adjusting for sex, smoking and age at first hospital admission the risk of developing
COPD in the co-twin of an affected twin was higher in MZ than in DZ twins, with hazards ratio
4.3 (95% confidence interval 1.2e15.8, pZ 0.03) in Danish twins and 3.4 (1.5e7.7, pZ 0.004)
in Swedish twins. According to the most parsimonious model, additive genetic factors5 31 68 21; fax: þ45 35 31 21 79.
gmail.com (T. Ingebrigtsen).
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Genetic influences on chronic obstructive pulmonary disease 1891explained 63% (46e77%) of the individual COPD-susceptibility in the Danish population and 61%
(48e72%) in the Swedish population.
Conclusion: The susceptibility to develop severe COPD, as defined by hospitalizations, is
strongly influenced by genetic factors. Approximately 60% of the individual susceptibility
can be explained by genetic factors.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a disease of
the airways and lung parenchyma that leads to airflow
limitation. COPD is characterized by inflammation within the
airways giving rise to bronchiolitis/small airways disease and
both inflammation and destruction distally of the terminal
bronchioles leading to emphysema.1,2 COPD is characterized
by progressive breathlessness, coughing, mucus hyperse-
cretion, fatigue and exacerbations.3e6 The disease is often
without symptoms for many years and is therefore typically
moderate to severe at the time of diagnosis.
The majority of patients with COPD have a history of
cigarette smoking, and smoking is the most important risk
factor for COPD, however, less than one half of all smokers
develop COPD, which indicates variation in the individual
susceptibility to COPD.7,8 Other risk factors for developing
COPD include occupation, socio-economic status and other
exposures (including biomass fuel burning).9
Alpha1-antitrypsin deficiency represents a hereditary
disorder that contributes considerably to the risk of
developing COPD in a small percentage of the population.10
Moreover, genetic linkage analyses point to susceptibility
loci for airflow limitation on several chromosomes including
2q11 and association analyses have shown relationship
between the SERPINE2 gene on chromosome 2q and
COPD.12,13 Besides these findings several other candidate
genes have shown association with COPD although these
associations have not been consistently replicated.14 A few
studies have demonstrated familial aggregation of
COPD,15,16 and some previous twins studies on pulmonary
function have quantified the genetic contribution to clini-
cally relevant parameters like forced expiratory volume in
1 s (FEV1) and forced vital capacity (FVC).
17
However, although the genetic contribution to develop
COPD has been recognized for many years18 an attempt to
accurately quantify this contribution has to our knowledge
never been conducted and so the overall genetic contri-
bution to the individual susceptibility to develop COPD has
actually never been accurately estimated. In this study we
quantified genetic and environmental influences on the
individual susceptibility to COPD as defined by hospitaliza-
tions and we therefore examined hospital discharge diag-
nosis data in large population-based samples of Danish and
Swedish twins.
Methods
Study populations
For our primary analysis we used data on Danish twins. The
Danish twin cohort analysed herein comprised twins bornbetween 1931 and 1982. A total of 22,422 twin pairs, 20e71
years of age, from the population-based Danish Twin
Registry,19 were identified and cross-linked with data on
hospitalization records from the Danish National Patient
Registry, an all-covering register of admissions with somatic
discharge diagnoses. The 22,422 twin pairs included 5592
monozygotic (MZ) pairs and 16,830 dizygotic (DZ) pairs. Of
these, 3431 MZ pairs and 8036 DZ pairs had data of COPD
hospital admission for both twins in a pair.
For replication analysis we used data on Swedish twins.
The Swedish twin cohort comprised Swedish twins born
between 1896 and 1958. A total of 27,668 twin pairs,
45e108 years of age, from the nationwide Swedish Twin
Registry20 were identified and cross-linked with the Swedish
National Patient Registry. The 27,668 twin pairs included
6653 MZ pairs and 21,015 DZ pairs. Of these 4316 MZ pairs
and 12,125 DZ pairs had data on both twins in a pair.
Data from the Danish Twin Registry were collected in
2007 while data from the Swedish Twin Registry were
collected in 2008. Zygosity among the Danish twins was
determined using four questions of similarity and mistaken
identity. This method assigns zygosity correctly in more
than 96% of the cases.21 Zygosity among the Swedish twins
was assigned based on questions about similarities in
childhood. This method has been validated repeatedly with
DNA testing as having 98% or higher accuracy.22
Smoking consumption e as pack-years e for the Swedish
twin cohort was calculated based on the questions: “How
many cigarettes/cigars/pipe-fills, have you been consuming
on an average per day” (for cigars and pipe-fills the numbers
was converted into numbers of cigarettes according to
general procedures) divided by “years of consumption”. The
same approach has been used to calculate pack-years in the
Danish twin cohort.
We used a hospital discharge diagnosis of COPD (both
primary and secondary diagnosis) as an indicator of pres-
ence of COPD in a twin. COPD discharge diagnosis data from
The Danish and the Swedish National Patient Registries
between 1977 and 2003 were available. ICD-8 codes were
used for diagnoses between 1977 and 1993; the specific ICD-
8 codes were: 490.09e492.09. ICD-9 codes were never used
in Denmark or Sweden. ICD-10 codes were used for diag-
nosis between 1994 and 2003; the specific ICD-10 codes
were: J40-J44.9.
Statistical analysis
The casewise concordance rate is the risk of disease in the
co-twin if his/her twin is affected. In this study, with
complete ascertainment, it is estimated by the proband-
wise concordance rate defined as two times the number of
concordant pairs (both twins in a pair are affected) divided
by the sum of two times the number of concordant pairs
1892 T. Ingebrigtsen et al.and the number of discordant pairs (one twin in a pair is
affected). Fisher’s exact test was applied to the Danish
concordance rate, and a Chi-square test to the Swedish
concordance rate (using SPSS version 16.0). Results are
presented as propandwise concordance rates with corre-
sponding p-values (from Fisher’s exact test and the Chi-
square test, respectively).
In order to investigate the genetic influence on the risk
based on discordant time we used the age at first hospital
admission for the first twin admitted in a twin pair and fitted
a Cox proportional hazards regression model to the concor-
dant and discordant pairs. In this analysis the time to admis-
sion for COPD in the co-twin of the first affected twin was the
underlying time23 and zygosity and sex were incorporated as
categorical covariates. Smoking defined as pack-years and the
age at hospitalization for COPD in the first affected twin were
incorporated as continuous covariates. Pairs of which one
twin had died before the co-twin was admitted to hospital
with a discharge diagnosis of COPD (negative survival) were
excluded from the analysis. In our analysis we used SPSS
version 16.0 and results are presented as hazards ratios (HR)
along with corresponding confidence intervals (95% CI’s).
Latent factor models of genetic and environmental
effects were fitted to the data using the statistical package
Mx (version 1.66b).24 These models assume that the
susceptibility to develop disease is a linear function of
genetic and environmental influences and estimate four
variance components A, C, D and E.25 Genetic influences
are partitioned into additive genetic effects, A, and
non-additive genetic effects, D. The two main types of
non-additivity are dominance and epistasis but since
epistatic genetic effects are usually confounded with
dominance genetic effects in quantitative genetic studies
of human populations, epistasis is not considered. Envi-
ronmental effects are partitioned into shared environ-
mental effects, C, and non-shared environmental effects,
E. The E term includes measurement error and can there-
fore never be zero. When only twin data are available (i.e.,
no data from other relatives), the effect of C and D are
confounded and only one of these factors can be estimated.
When the probandwise concordance rate for MZ twins is
higher than two times the probandwise concordance rate
for the DZ twins, one should fit an ADE model to the data
and when it is less than two one should fit an ACE model.25
To test the significance of the contribution of the individual
variance components to the disease susceptibility sub-
models were subsequently fitted by successively removing
variables from the full model. In this instance the DE model
is not considered biologically plausible and is therefore not
fitted, while an AE model and an E model can be fitted.26
Results are presented as the percentage that each vari-
ance component A, C, D and E explains within each fitted sub-
model, alongwith corresponding p-values (provided by theMx
software) for deterioration in fit compared to the full model.
Results
Table 1 shows study population characteristics. The mean
age of the Danish population was 44.1 years (95% confi-
dence interval 43.9e44.3) for the females and 45.0 years
(44.8e45.2) for the males, respectively, while the meanage of the Swedish population was 67.7 years (67.6e67.8)
for the females and 66.6 (66.5e66.7) for the males.
A total of 1.4% of the Danish twin population and a total
of 2.0% of the Swedish twin population had been admitted
to hospital with a COPD discharge diagnosis. The most
frequent diagnosis registered was J44.9 (COPD, unspeci-
fied) in both cohorts (Table 2). Among the complete twin
pairs (discharge data on both twins in a pair) we found
a total of 272 cases of COPD in the Danish twin cohort and
a total of 527 cases in the Swedish cohort.
Table 3 shows the probandwise concordance rates. In
the Danish twins the probandwise concordance rate for
COPD was higher for MZ twins than for DZ twins, 0.19 vs.
0.07 (pZ 0.08), although not statistically significant, which
was replicated by 0.20 vs. 0.08 (p Z 0.006) in the Swedish
twins.
In the Danish twin cohort, the adjusted Cox regression
analysis showed that if a twin was admitted to hospital with
COPD as discharge diagnosis then, subsequently, MZ co-twins
had a higher risk of also being admitted with a discharge
diagnosis of COPD than DZ co-twins, hazard ratio 4.3
(1.2e15.8), p Z 0.03, while sex, age and smoking were not
significant (p > 0.05). In a similar model in the Swedish
replication cohort, hazard ratiowas 3.4 (1.5e7.7), pZ 0.004,
sex and age was not significant (p> 0.05), but pack-years had
a significant impact on admissions, HRZ 1.05 (1.03e1.07) per
pack-year. Univariate analysis (including only zygosity as
covariate) estimated HRZ 3.0 (1.0e9.0) in the Danish twin
cohort and HRZ 2.9 (1.4e6.1) in the Swedish cohort.
Table 4 shows variance component estimates. Additive
genetic factors explained 63% (46e77%) and unique envi-
ronmental factors 37% (23e54%) of the individual suscep-
tibility to COPD among Danish twins. In replication analyses
of the Swedish cohort, findings only differed slightly with an
additive genetic contribution of 61% (48e72%) and a unique
environmental contribution of 39% (29e52%).
Subsequent analyses among twins concordant for having
a smoking history (more than zero pack-years) showed that
additive genetic factors explained 61% (39e78%) of the
susceptibility to COPD among Danish twins and 75%
(60e86%) among Swedish twins.
Discussion
This study showed almost identical results in terms of
a higher concordance for COPD, as defined by hospitaliza-
tions, in monozygotic twins relative to dizygotic twins in
Danish and Swedish twins. We estimated that approxi-
mately 60% of the variation in individual susceptibility to
COPD as defined by hospitalizations was ascribable to
genetic factors, specifically an additive genetic contribu-
tion (A) of 63% and a unique environmental contribution (E)
of 37% (most parsimonious model) in the Danish twin
cohort, and an additive genetic contribution of 61% and
a unique environmental contribution of 39% in the Swedish
twin cohort.
In the cox-regression model we adjusted the genetic
contribution for the COPD risk factors age, sex and smoking
showing that as time passes the risk of being admitted to
hospital with a discharge diagnosis of COPD is substantially
larger in the co-twin of a affected monozygotic twin than for
Table 1 Characteristics of the two study populations.
DENMARK
Age group (years) 20e30 31e40 41e50 51e60 61e71 Total
N (%) N (%) N (%) N (%) N (%) N (%)
Sexb
Males 2942 (43.4) 3438 (42.9) 3490 (47.5) 3706 (46.8) 2439 (47.2) 16015 (45.5)
Females 3830 (56.6) 4577 (57.1) 3860 (52.5) 4218 (53.2) 2730 (52.8) 19215 (54.5)
COPDc 15 (0.2) 29 (0.4) 59 (0.8) 145 (1.8) 228 (4.4) 476 (1.4)
Smoking (pack years)d
None 3869 (58.8) 3803 (48.7) 2791 (39.5) 2740 (36.6) 1518 (33.1) 14721 (43.9)
<5 722 (11.0) 697 (8.9) 649 (9.2) 833 (11.1) 635 (13.8) 3536 (10.5)
5e20 1848 (28.1) 2862 (36.7) 2985 (42.3) 3273 (43.7) 2113 (46.0) 13081 (39.0)
>20 139 (2.1) 444 (5.7) 635 (9.0) 648 (8.6) 325 (7.1) 2191 (6.5)
Percentage of COPD
cases with a history of smokinga
53 89 89 87 91 88
SWEDEN
Age group (years) 45e50 51e60 61e70 71e80 81e90 91e108 Total
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Sex
Males 606 (46.0) 6489 (51.5) 6637 (47.0) 4400 (47.8) 2400 (42.0) 347 (29.9) 20879 (46.5)
Females 711 (54.0) 6899 (48.5) 7485 (53.0) 4811 (52.2) 3320 (58.0) 814 (70.1) 24040 (53.5)
COPD 4 (0.3) 47 (0.4) 183 (1.3) 323 (3.5) 282 (4.9) 39 (3.4) 878 (2.0)
Smoking (pack years)
None 547 (47.9) 4801 (40.6) 5225 (41.9) 4622 (59.8) 3569 (76.6) 908 (88.4) 19672 (50.6)
0e5 158 (13.8) 1544 (13.0) 1210 (9.7) 484 (6.3) 218 (4.7) 32 (3.1) 3646 (9.4)
5e20 317 (27.8) 3398 (28.7) 3080 (24.7) 1111 (14.4) 421 (9.0) 52 (5.1) 8379 (21.6)
>20 119 (10.4) 2094 (17.7) 2963 (23.7) 1513 (19.6) 453 (9.7) 35 (3.4) 7177 (18.5)
Percentage of COPD
cases with a history of smokinga
100 91 91 78 55 41 74
a More than zero pack years defines smoking.
b The sum of males and females is less than the two times the number of total twin pairs reported since not all pairs had complete data
on both twins in a pair.
c The COPD cases is the total number of individual twin cases, while our analyses reported in the results section are based on only
complete twin pairs.
d The sum of twins with information on smoking habits is less than the sum of males and females due to missing smoking status for some
of the twins.
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Danish twin cohort and hazard ratio was 3.4, in the Swedish
cohort.
The strength of this study comes from its use of two
large twin cohorts with linkage to nationwide hospital
registers in countries with very similar national health
services. The twin cohorts represented a large part of the
total population of Danish and Swedish twins. Furthermore,
this investigation used objective hospital discharge diag-
noses of COPD limiting bias due to recall and ascertain-
ment. In both countries, doctors and not administrators,
often doctors at specialist level code diagnoses at
discharge. In addition, hospitals in both Denmark and
Sweden hold a strong tradition of performing spirometry
before discharging of COPD patients. Although these
spirometry records were not accessible for the present
study, the fact that spirometry was performed at discharge
minimizes the possibility that the cases in this study were
not real COPD cases but, e.g., people with other severelung diseases. However, we cannot preclude that COPD in
some cases is more a comorbidity than the main diagnoses,
but given the general underdiagnosis of COPD we believe
this to be a minor concern.
In our study we used both ICD-8 and ICD-10 coding in two
different countries. Generally we have no reason to assume
that coding should have been different in the two countries
since we have used data from countries that are very alike
with respect to education, health systems and traditions of
treatment, which reduces the variation and insecurities in
our estimates. With respect to ICD codings, ICD-10 was used
from 1994 onward and ICD-8 before 1994, but we do not
have any reason to believe that monozygotic and dizygotic
twins should have been coded differently in the two
different periods, which could have caused variation.
In the Danish twin cohort we found one concordant pair
and 22 discordant pairs less than 40 years of age. Considering
the low age we speculate that these young pairs represent
alpha1-antitrypsin deficiency, asthma or perhaps coding
Table 2 Shows ICD-8 or ICD-10 codes found in the Danish
or Swedish twin registry along with corresponding numbers
of discharge diagnoses.
Sweden Denmark
ICD-8
490.09 0 8
491.00 0 3
491.01 6 1
491.02 4 3
491.03 0 3
491.04 10 0
491.08 0 2
491.09 39 44
492.00 0 1
492.01 0 5
492.08 0 1
492.09 0 1
ICD-10
J 40.9 0 18
J 41.0 13 23
J 41.1 5 7
J 41.8 1 2
J 42.9 35 83
J 43.1 2 1
J 43.2 2 0
J 43.8 1 0
J 43.9 51 27
J 44.0 83 5
J 44.1 129 66
J 44.8 23 9
J 44.9 474 163
Table 4 Variance components analysis of COPD in Danish
and Swedish twin pairs.
Model A D E P-valuea
Denmark
ADE 58 (0e77) 7 (0e75) 36 (21e54)
AE 63 (46e77) e 37 (23e54) 0.86
E e e 100 <0.001
Sweden
ADE 61 (16e72) 0 (0e50) 39 (27e52)
AE 61 (48e72) e 39 (29e52) 1.00
E e e 100 <0.001
Standardized parameter estimates (95% confidence intervals) of
additive genetic factors (A), non-additive genetic factors (D),
and non-shared environmental factors (E).
a P-value for deterioration in fit between full model and sub-
model.
1894 T. Ingebrigtsen et al.errors. In order to investigate this, a sensitivity analysis in
the Danish twin cohort among the twins with age above 40
years estimated an additive genetic contribution of 55% (95%
CI 35e72%) to the individual susceptibility of COPD.
A limitation of this study is that a hospital discharge
diagnosis could indicate that the COPD cases represent
COPD patients with frequent exacerbations or patients with
very severe disease. As we did not have access to data
specifying primary vs. secondary diagnoses we suspect that
maybe a calculation based on only primary diagnoses could
be closer to estimating the genetic contribution to devel-
oping severe COPD. We were not able to evaluate the exact
clinical severity or sub-type of COPD from the data but weTable 3 Concordance for COPD hospitalizations among Danish
Pairs (total) Pairs (complete) D
Denmark 22,422 11,467
MZ 5,592 3,431
DZ 16,830 8,036 1
Sweden 27,668 16,441
MZ 6,653 4,316
DZ 21,015 12,125 3
Cpr is probandwise concordance rate; MZ is monozygotic twin pairs;
a P-value for test of differential concordance rates in MZ and DZ twexpect that a number of the co-twins without a hospital
admission would be diagnosed with COPD if clinically
examined with spirometry since COPD is often undiagnosed
for many years, thus, our results could relate to genetic
determinants of COPD exacerbations or COPD severity.
However, in this study design speculations about a probable
COPD diagnosis of the co-twins based on spirometry is not
important. From the perspective of establishing the extent
of genetic influences on COPD, it is important that the
comparison of twin pairs in the shape of the concordance
and discordance rates in monozygotic and dizygotic twins,
are based on a clear and comparable phenotype, as these
dis-/concordance rates are the unit of analysis. In this
respect, differential admission of monozygotic and dizy-
gotic twins would lead to bias, but we do not think this is at
all likely to have occurred.
Another potential limitation of the study is the fact that
even if smoking habits vary between Denmark and Sweden,
tobacco smoking is still undoubtedly the most significant
environmental exposure related to COPD.27 However, in
other parts of the world exposures to indoor biomass fuel
may play a more prominent role and, at least theoretically,
our findings can not be translated to that situation.28
Several studies have indicated that genetics play
a larger role in COPD than previously anticipated and
a recent large twin study has indicated a genetic inter-
action with smoking in respect to the development of
chronic bronchitis29 which supports findings in a previousand Swedish twin pairs.
iscordant Concordant Cpr MZ Z DZ
a
52 6 0.19
94 7 0.07 0.08
97 12 0.20
74 16 0.08 0.006
DZ is dizygotic twin pairs.
ins.
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non-twin siblings has shown that individual traits such as
extent of emphysema and airway size show independent
aggregation within families of individuals with COPD.31
Linkage analysis has provided significant evidence for an
early-onset COPD-susceptibility locus on chromosome 2,32
and recently the first genome-wide association study of
COPD identified SNPs at the nicotinic acetylcholine
receptor locus as well as at the hedgehog interaction
protein locus in a case-control study and two large repli-
cation cohort studies.33
Our results support the view of a very significant genetic
impact on the susceptibility to COPD and we give here the
first attempt to accurately quantify the overall genetic
contribution to the individual susceptibility to the disease.
We estimate that approximately 60% of the individual
differences observed in COPD hospitalizations can be
explained by genetic factors.
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